![Dollar strengthens ahead of PCE data; euro weighed by political uncertainty](https://i-invdn-com.investing.com/news/LYNXMPEEB40Y1_S.jpg)
Please try another search
Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers worldwide. It offers recombinant proteins, antibodies, cDNA clones, kits, and other reagents that are used in the areas of cancer, cardiovascular biology, cell and developmental biology, epigenetics, immunology, neuroscience, signal transduction, and stem cells. The company also provides pre-clinical production technology services for monoclonal antibody drug candidates; and custom services, such as protein production, antibody development and production, biological assay, and protein expression services. It serves academic research institutions, biotech companies, and pharmaceutical companies. The company was founded in 2016 and is headquartered in Beijing, China.
Name | Age | Since | Title |
---|---|---|---|
Liangzhi Duan | - | - | Chairman of the Board |
Yanmin Tang | 51 | - | Non-Independent Director |
Baiyang Sheng | - | 2023 | Non-Independent Director |
Shizhou Yin | 50 | - | Independent Director |
Xiaofang Chen | 55 | - | Non-Independent Director |
Changyuan Yu | 61 | - | Independent Director |
Yong You | - | 2023 | Independent Director |
Daniel I. C. Wang | - | - | Chairman of Scientific Advisory Board |
Jing Wang | 39 | 2020 | Chairman of the Supervisory Board |
Ran Gao | 38 | 2020 | Employee Representative Supervisor |
Liangzhi Xie | 58 | 2007 | Founder, President & Chairman |
Tao Feng | 43 | 2020 | CFO, Secretary to the Board & Non-Independent Director |
Zhang Jie | 51 | 2018 | GM, MD, R&D Director & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review